ArticleCureus2026

Extreme Hyperhemolysis Syndrome in a Patient With Sickle Cell Disease Successfully Managed With Eculizumab: A Case of Survival at 1.2 g/dL Hemoglobin.

Isa Cordeiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.